Appendix A
Learning from SARS: Preparing for the Next Disease Outbreak

September 30-October 1, 2003

SMITHSONIAN S. DILLON RIPLEY CENTER WASHINGTON, DC

AGENDA

TUESDAY, SEPTEMBER 30, 2003

8:30

Continental Breakfast

9:00

Welcome and Opening Remarks

Adel Mahmoud, M.D., Ph.D.

Chair, Forum on Emerging Infections

President, Merck Vaccines

RECAPPING THE EVENTS: EXPERIENCES FROM THE FIELD

Session I: The Evolution of the Outbreak

Moderator: Harvey Fineberg, President, Institute of Medicine

9:15-9:40

CHINA: The Epicenter

Yi Guan, M.D., Ph.D., The University of Hong Kong, Queen Mary Hospital

9:40-10:00

Discussion

10:00-10:25

SARS: Lessons from Toronto

Don Low, M.D., FRCPC., Toronto Medical Laboratories, Mt. Sinai Hospital, Toronto

10:25-10:45

Discussion



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 277
Learning From Sars: Preparing for the Next Disease Outbreak - Workshop Summary Appendix A Learning from SARS: Preparing for the Next Disease Outbreak September 30-October 1, 2003 SMITHSONIAN S. DILLON RIPLEY CENTER WASHINGTON, DC AGENDA TUESDAY, SEPTEMBER 30, 2003 8:30 Continental Breakfast 9:00 Welcome and Opening Remarks Adel Mahmoud, M.D., Ph.D. Chair, Forum on Emerging Infections President, Merck Vaccines RECAPPING THE EVENTS: EXPERIENCES FROM THE FIELD Session I: The Evolution of the Outbreak Moderator: Harvey Fineberg, President, Institute of Medicine 9:15-9:40 CHINA: The Epicenter Yi Guan, M.D., Ph.D., The University of Hong Kong, Queen Mary Hospital 9:40-10:00 Discussion 10:00-10:25 SARS: Lessons from Toronto Don Low, M.D., FRCPC., Toronto Medical Laboratories, Mt. Sinai Hospital, Toronto 10:25-10:45 Discussion

OCR for page 277
Learning From Sars: Preparing for the Next Disease Outbreak - Workshop Summary 10:45-11:10 WHO: The Global Response David Heymann, M.D., World Health Organization, Geneva 11:10-11:30 Discussion 11:30 BREAK Session II: Discussion Panel Moderator: Stanley Lemon, M.D., Vice Chair, Forum on Emerging Infections/Dean of Medicine, The University of Texas Branch at Galveston 11:45 Discussants: Reporting Tools and Surveillance Networks: Ann-Marie Kimball, M.D., M.P.H., School of Public Health and Community Medicine, University of Washington International Coordination and Collaboration: Ray Arthur, Ph.D., National Center for Infectious Diseases, Global Health, CDC (Invited) Animal Coronaviruses—Lessons from SARS: Linda Saif, Ph.D., Ohio Agricultural Research Center, Ohio State University 12:30 Open Discussion   1:00 Lunch   Session III: The Spectrum of Consequences and Responses Moderator: James Hughes, M.D., NCID, CDC 2:00-2:25 Economic Impacts Warwick McKibbin, Ph.D., Australian National University 2:25-2:45 Discussion 2:45-3:10 The Implications of SARS Epidemic for China’s Public Health Infrastructure and Political System Yanzhong Huang, Ph.D., Seton Hall University, Whitehead School of Diplomacy and International Relations, Center for Global Health Studies 3:10-3:30 Discussion

OCR for page 277
Learning From Sars: Preparing for the Next Disease Outbreak - Workshop Summary 3:30-3:55 Quarantine and Containment Strategies Marty Cetron, M.D., National Center for Infectious Diseases, CDC 3:55-4:15 Discussion 4:15-4:40 Impacts on Health Care Systems G. Neil Thomas, M.D., Department of Community Medicine, University of Hong Kong (Invited) 4:40-5:00 Discussion Session IV: Open Discussion 5:00 Moderator: Joshua Lederberg, Ph.D., Nobel Laureate, Sackler Foundation Scholar, Rockefeller University Open Discussion 6:00 Adjournment of the first day WEDNESDAY, OCTOBER 1, 2003 8:30 Continental Breakfast 9:00 Opening Remarks/Summary of Day 1 Stanley Lemon, M.D. Vice Chair, Forum on Emerging Infections LEARNING FROM OUR LESSONS: THE AGENDA AHEAD Session V: The Research Agenda and Emerging Technologies Moderator: Carole Heilman Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID, NIH 9:15-9:40 Coronavirus Research Mark Denison, M.D., Vanderbilt University 9:40-10:00 Discussion 10:00-10:25 TIGER Technology for Emerging Infectious Disease Surveillance Ranga Sampath, Ph.D., Ibis Therapeutics, A Division of Isis Pharmaceuticals 10:25-10:45 Discussion

OCR for page 277
Learning From Sars: Preparing for the Next Disease Outbreak - Workshop Summary 10:45-11:20 Pharmaceutical Approaches to Antiviral Drug Development Amy Patick, Ph.D. and Peter Dragovich, Ph.D., Pfizer Inc. 11:20-11:30 Discussion 11:30 BREAK 11:45-12:10 Vaccines: Can We Prevent the Unexpected? Alan Shaw, Ph.D., Merck Research Laboratories 12:10-12:30 Discussion 12:30-12:50 SARS: Clearing the Air Jerome Schentag, Pharm.D., State University of New York-Buffalo 12:50-1:00 Discussion 1:00 LUNCH Session VI: Panel Discussion—Preparing for the Next Disease Outbreak Moderator: Frederick Sparling, M.D., Professor of Medicine, Microbiology, and Immunology, University of North Carolina 2:00 Discussants: The Quest to Define and Control SARS: Robert Breiman, M.D., Centre for Health and Population Research, Dhaka, Bangladesh Regulatory Laboratory Planning/Preparedness: Kathryn Carbone, M.D., Center for Biologics, Food and Drug Administration Future Threats Assessment: Karen Monaghan, NIC, National Intelligence Council Report Public Health Law: Gene Matthews, J.D., Legal Advisor to CDC Modeling a Response Strategy: Nathaniel Hupert, M.D., M.P.H., Weill Cornell Medical College Face to Face w/Influenza: Robert Webster, Ph.D., St. Jude Children’s Research Hospital 3:30 Open Discussion 5:00 Closing Remarks/Adjourn